Literature DB >> 24446426

Sentinel lymph node status in Merkel cell carcinoma of the head and neck: not a predictor of survival.

Valerie A Fritsch1, E Ramsay Camp, Eric J Lentsch.   

Abstract

BACKGROUND: The effect of sentinel lymph node status on survival in patients with Merkel cell carcinoma (MCC) of the head and neck is uncertain.
METHODS: We used the Surveillance Epidemiology and End Results (SEER) database to identify patients with MCC who underwent sentinel lymph node biopsy (SLNB). Clinicopathologic data and disease-specific survival (DSS) were compared among patients with positive and negative sentinel lymph nodes.
RESULTS: We identified 721 patients with cutaneous MCC who underwent SLNB, of which 173 (24%) had head and neck MCC. The rate of sentinel lymph node positivity in patients with head and neck MCC was 23.1%. Sentinel lymph node metastasis did not significantly affect survival in head and neck MCC (p = .139).
CONCLUSION: Using the SEER database, we report what we believe to be the largest head and neck MCC study to date. Our results suggest that sentinel lymph node status does not predict survival in head and neck MCC. Independent predictors of MCC-related mortality seem to be unique in the head and neck region.
Copyright © 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  Merkel cell carcinoma; head and neck; lymphoscintigraphy; prognosis; sentinel lymph node biopsy

Mesh:

Year:  2014        PMID: 24446426     DOI: 10.1002/hed.23334

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  8 in total

1.  Patterns of Metastasis in Merkel Cell Carcinoma.

Authors:  Yun Song; Feredun S Azari; Rebecca Tang; Adrienne B Shannon; John T Miura; Douglas L Fraker; Giorgos C Karakousis
Journal:  Ann Surg Oncol       Date:  2020-05-13       Impact factor: 4.339

2.  Molecular imaging and therapy of merkel cell carcinoma.

Authors:  Volkan Beylergil; Jorge A Carrasquillo
Journal:  Cancers (Basel)       Date:  2014-04-29       Impact factor: 6.639

3.  Head and Neck Merkel Cell Carcinoma: A 12-Year Single Institutional Experience.

Authors:  C M Hurley; D ALNafisee; D Jones; J L Kelly; P J Regan; A J Hussey; N McInerney
Journal:  JPRAS Open       Date:  2022-05-14

Review 4.  Prognostic significance of sentinel lymph node mapping in Merkel cell carcinoma: systematic review and meta-analysis of prognostic studies.

Authors:  Ramin Sadeghi; Zohreh Adinehpoor; Masoud Maleki; Babak Fallahi; Luca Giovanella; Giorgio Treglia
Journal:  Biomed Res Int       Date:  2014-05-26       Impact factor: 3.411

5.  Understanding the influence of patient demographics on disease severity, treatment strategy, and survival outcomes in merkel cell carcinoma: a surveillance, epidemiology, and end-results study.

Authors:  Harib H Ezaldein; Alessandra Ventura; Nicolaas P DeRuyter; Emily S Yin; Alessandro Giunta
Journal:  Oncoscience       Date:  2017-09-14

6.  Prognostic Factors in Merkel Cell Carcinoma: A Retrospective Single-Center Study in 90 Patients.

Authors:  Marco Rastrelli; Beatrice Ferrazzi; Francesco Cavallin; Vanna Chiarion Sileni; Jacopo Pigozzo; Alessio Fabozzi; Saveria Tropea; Antonella Vecchiato; Alessandra Costa; Alessandro Parisi; Carlo Riccardo Rossi; Paolo Del Fiore; Mauro Alaibac
Journal:  Cancers (Basel)       Date:  2018-09-24       Impact factor: 6.639

Review 7.  Merkel Cell Carcinoma: New Trends.

Authors:  Ellen M Zwijnenburg; Satish F K Lubeek; Johanna E M Werner; Avital L Amir; Willem L J Weijs; Robert P Takes; Sjoert A H Pegge; Carla M L van Herpen; Gosse J Adema; Johannes H A M Kaanders
Journal:  Cancers (Basel)       Date:  2021-03-31       Impact factor: 6.639

8.  Treatment of Locally Advanced Merkel Cell Carcinoma-A Multi-Center Study.

Authors:  Monika Dudzisz-Sledz; Paweł Sobczuk; Katarzyna Kozak; Tomasz Switaj; Hanna Kosela-Paterczyk; Anna Malgorzata Czarnecka; Slawomir Falkowski; Paweł Rogala; Tadeusz Morysinski; Mateusz Jacek Spalek; Marcin Zdzienicki; Tomasz Goryn; Marcin Zietek; Bozena Cybulska-Stopa; Stanisław Klek; Grazyna Kaminska-Winciorek; Barbara Ziolkowska; Anna Szumera-Cieckiewicz; Piotr Rutkowski
Journal:  Cancers (Basel)       Date:  2022-01-14       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.